Delivery Order SPE2DB20D1004-SPE2DB22FE7V7
Award Date
10/25/21
Potential Completion Date
10/26/21
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,212.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC is valued at up to $999,999,999.00 and runs through November 2026, serving as the primary vehicle for Amerisourcebergen...
This federal contract award, valued at $1,956.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESTROGEL 0.06% GEL 37.5GM, a medical product, and is a Firm Fixed Price Delivery Order with an ultimate completion date of February 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ESTROGEL 0.06% GEL 37.5GM. The firm-fixed-price delivery order, valued at $1,079.16, has a completion date of December 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ESTROGEL 0.06% GEL 37.5GM. The contract is a Delivery Order with a Firm Fixed Price of $1,315.99 and an ultimate completion date of September 23, 2024. The award does not have a set-aside designation. Amerisourcebergen, through its Corporate Office division, has been awarded multiple federal contracts and Indefinite Delivery Contracts...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,591.66 firm fixed-price delivery order is for the supply of ESTROGEL 0.06% GEL 50GM, a topical medication. The award has an ultimate completion date of May 9, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
The federal contract award is for the delivery of ESTROGEL 0.06% GEL 50GM to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,029.98, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 2, 2024. The contract is a delivery order with a firm fixed price, and the ultimate completion date is August 5, 2024. There is no set-aside designation for this contract. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical company Amerisourcebergen Corporation. The $3,253.76 firm fixed price delivery order is for the supply of ESTROGEL 0.06% GEL 50GM, a pharmaceutical product, with a completion date of January 9, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. As a key supplier of...
This federal contract award with ID SPE2DB24D1007|SPE2DB25FBZNX was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,041.22 firm fixed price delivery order is for the medical product ESTROGEL 0.06% GEL 37.5GM. This award is not designated under any set-aside program. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5, 2024. AmerisourceBergen holds a...
This is a $3,207.49 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ESTROGEL 0.06% GEL 37.5GM, a medical product, to support military healthcare programs. The contract has an ultimate completion date of February 24, 2025. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $617 to Amerisourcebergen Drug Corporation for ESTROGEL 0.06% gel in 50 gram containers. The single day order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility to support the Defense Logistics Agency's medical supply needs. No additional details were provided regarding the context or purpose of the requested products. The award utilizes no set aside designations and does not...